Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9326315 | Gynecologic Oncology | 2005 | 5 Pages |
Abstract
Limiting adjuvant treatment to vault brachytherapy for node-negative stage II endometrial cancer results in less morbidity and excellent survival and is worthy of further investigation.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Paula V.C. Rittenberg, Robert J. Lotocki, Mark S. Heywood, Garry V. Krepart,